Search

Search Constraints

You searched for: Author/Creator Mierzynska, Justyna

Search Results

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

2. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. Issue 12 (December 2019)

3. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer. (January 2020)

4. Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors. (28th February 2021)